BLS Pharmaceuticals LimitedASX: BLS

Ceasing to be a substantial holder

· Issued by BLS Pharmaceuticals Limited via ASX

Filed with ASX · · 2 pages · English

Release

605 page 1/2 15 July 2018 Form 605 Corporations Act 2001 Section 671B Notice of ceasing to be a substantial holder To Company/registered scheme/notified foreign passport fund name BLS Pharmaceuticals Limited ACN/ARSN/APFRN ACN 084 464 193 NFPFRN (if applicable) 1.Details of substantial holder...

BLS Pharmaceuticals Limited on 6ix

Earlier from BLS Pharmaceuticals

Later from BLS Pharmaceuticals

All BLS Pharmaceuticals news releases